Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND AND AIMS: Traditional Chinese medicine (TCM) therapy for hepatocellular carcinoma remains controversial. This study aimed to evaluate the efficacy and safety of TCM regimens in HCC treatment. METHODS: Randomized controlled trials (RCTs) up to June 1, 2016, of the TCM treatment for hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zongguo, Liao, Xian, Lu, Yunfei, Xu, Qingnian, Tang, Bozong, Chen, Xiaorong, Yu, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478821/
https://www.ncbi.nlm.nih.gov/pubmed/28680448
http://dx.doi.org/10.1155/2017/3428253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478821/
https://www.ncbi.nlm.nih.gov/pubmed/28680448
http://dx.doi.org/10.1155/2017/3428253

Ejemplares similares